BIOAGE LABS, INC. — Cash Flow Charts
7 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-17M
Free Cash Flow↓-330.8% -$86K
$-112K
Investing Cash Flow
$13M
Financing Cash Flow↓-35.7% -$9M
$16M
Capex↑+330.8% +$86K
$112K
Stock-Based Comp↑+0.0% +$1K
$3M
Debt Issued
—
Debt Repaid↑+0.0% +$0
$2M
D&A↑+0.0% +$0
$100K
SBC Allocated Expense↑+0.0% +$1K
$3M